Abbott (ABT) – General News
-
Midday movers: Travelers, JB Hunt fall; United Airlines rises
-
Midday movers: Adobe, Zillow fall; Micron rises
-
Reckitt to challenge $60 million baby formula verdict, shares sink
-
Midday movers: Netflix gains, ASML spurs rally in chip stocks
-
Analysts downplay Medicare cost-cutting impact on Dexcom as shares drop 5%
-
Abbott to cease sale of infant probiotic products after FDA warning
-
Medical device makers see limited hit from weight-loss drugs
-
Midday movers: Netflix, Intuitive Surgical, Western Alliance Bancorp and more
-
Apple (AAPL) makes non-invasive glocose monitoring breakthrough - Bloomberg
-
FDA Pathway Supports Long-Term Stability, Diversity of Safe and Nutritious Infant Formula Supply in the U.S.
-
Abbott completes India recall of baby formula products imported from U.S
-
Abbott, FDA reach agreement to reopen baby formula facility in Michigan
-
Abbott cuts sales growth forecast on baby formula recall
-
Abbott Labs CEO expects strong COVID-19 testing demand in near term
-
Abbott raises annual earnings outlook as COVID-19 test sales rebound
-
Abbott beats profit estimates as medical device sales rebound
-
Abbott says new data shows rapid COVID-19 test used at White House is highly accurate
-
U.S. to send millions of rapid COVID-19 tests to states to support school reopening, other tasks
-
U.K. Buys 10 Million Antibody Tests From Roche and Abbott (ABT) - Bloomberg
-
U.S. health secretary expresses confidence in Abbott's fast COVID-19 test
-
'A disaster': Roche CEO's verdict on some COVID-19 antibody tests
-
CVS ramps up drive-through coronavirus testing sites with faster kits
-
Wall Street rallies, led by healthcare jump
-
Abbott hits all-time high on quarterly revenue beat
-
Abbott CEO Miles White to step down next year
-
Abbott revenue misses as heart devices eclipse diabetes gains
-
Abbott hits record high as diabetes device fuels profit beat
-
Wall St. falls as CSX results signal damage from trade tensions
-
AbbVie CFO Chase to retire by mid-year 2019
-
Abbott sticks to earlier forecasts, disappoints investors
-
Recent hurricanes take toll on quarterly earnings
-
Pfizer (PFE), Abbott (ABT), Novartis (NVS) Submitting Bids for Ache
-
Abbott's (ABT) $14.7B bond sale set to be the biggest since FY09
-
FDA panel votes 15-1-1 that Abbott's (ABT) Humira benefit is meaningful
-
FDA panel votes 3-14 that Abbott (ABT) has not found right Humira dose
-
Abbott's (ABT) Niaspan Failed to Protect Heart in Study - Bloomberg
-
StreetInsider.com Trading Radar 10/17
-
StreetInsider.com Pre-Open Movers 07/12
-
StreetInsider.com Trading Radar 04/18
-
Largest $ Movers of Note - StreetInsider.com - 03/26/2007
-
The Dow Adds 120 Points, Nasdaq Adds 35
-
StreetInsider.com Pre-Open Movers 11/06
-
StreetInsider.com Trading Radar 10/18
-
StreetInsider.com Trading Radar 07/19
-
Daily Block Trades of Note 07/13: ABT, MT, RGC, PXT, PTEC
Back to ABT Stock Lookup